Moors & Cabot’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$225K	Buy	44,550 +680	+2%	+$3.44K	0.01%	760
2025 Q1	$232K	Buy	+43,870	New	+$232K	0.01%	729
2024 Q2	–	Sell	-13,500	Closed	-$135K	–	901
2024 Q1	$135K	Buy	+13,500	New	+$135K	0.01%	847